Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
3 papers
Recent·Most cited
L. J. Finney, N. Glanville, H. Farne…·A. Singanayagam
This study shows inhaled corticosteroids reduce ACE2 expression in COPD, potentially lowering SARS-CoV-2 susceptibility by suppressing type I interferon.
A. Singanayagam, J. Footitt, B. T. Kasdorf…·S. L. Johnston
This study identifies MUC5AC as a driver of COPD exacerbation severity by amplifying virus-induced airway inflammation through ATP release.
A. Singanayagam, S.-L. Loo, M. Calderazzo…·P. Mallia
This study identifies impaired anti-viral and anti-microbial immunity in COPD patients with frequent exacerbations, linking reduced interferon and MBL-2 levels to increased bacterial loads and susceptibility to exacerbations.